Trial Profile
Phase III program of JZP-8 in patients with recurrent acute repetitive seizures.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Clonazepam (Primary)
- Indications Seizures
- Focus Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 08 Mar 2011 Jazz Pharmaceuticals expects to conduct an additional phase II trial of JZP-8 in 2011 prior to phase III activities.
- 19 Mar 2008 New trial record.